<DOC>
	<DOCNO>NCT02804087</DOCNO>
	<brief_summary>To evaluate safety performance MobiusHD system subject resistant hypertension .</brief_summary>
	<brief_title>Controlling And Lowering Blood Pressure With MobiusHDTM Device</brief_title>
	<detailed_description>This prospective , randomize , double-blind , sham-controlled , multi-center post market study investigate efficacy safety MobiusHD System , efficacy MobiusHD device lower mean systolic 24-hour ABP subject resistant hypertension .</detailed_description>
	<criteria>Aged 1870 year ; Diagnosed resistant hypertension ; A mean systolic 24hour ABP 135170 mmHg follow least 30 day stable antihypertensive medication regimen ( change medication dose ) . A mean systolic 24hour ABP 135170 mmHg washout antihypertensive medication . Known clinically suspect baroreflex failure autonomic neuropathy Treatable cause resistant hypertension Hypertension secondary identifiable treatable cause sleep apnea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>